drugset
drugset / Trial / NCT04453306

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

NCT04453306 ↗

Phase 4 Unknown 80 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Treatment of obesity related to Polycystic Ovary Syndrome with topiramate or placebo to assess improvement of clinical and laboratory parameters after 6 months of follow-up

Timeline

Start
2014-05
Primary completion
2021-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 50 mg —
Subject Topiramate Small molecule 100 mg —

Indications

obesity disorder polycystic ovary syndrome